TIDMSMH 
 
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF YOU ARE IN 
ANY DOUBT AS TO THE ACTION YOU SHOULD TAKE, YOU SHOULD SEEK ADVICE FROM YOUR 
INDEPENT LEGAL, TAX, FINANCIAL OR PROFESSIONAL ADVISOR IMMEDIATELY. 
 
 
                    VanEck VectorsT Semiconductor UCITS ETF 
 
                                 (THE "FUND") 
 
                                 A SUB-FUND OF 
 
                        VanEck VectorsT UCITS ETFs plc 
 
        (an umbrella fund with segregated liability between sub-funds) 
 
   A company incorporated with limited liability as an open-ended investment 
company with variable capital under the laws of Ireland with registered number 
                                    548554 
 
 
NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE FUND 
AT 33 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND AT 10:30 A.M. (IRISH TIME) ON 
2 MARCH 2022 AS SET OUT IN APPIX 1. 
 
If you have sold or transferred your Shares in the Fund, please forward this 
document and the accompanying proxies to the purchaser, transferee or other 
agent through whom the sale or transfer was effected. 
 
The Directors of the Company accept responsibility for the accuracy of the 
contents of this document. 
 
 
 
                        VanEck VectorsT UCITS ETFs plc 
 
        (an umbrella fund with segregated liability between sub-funds) 
 
   A company incorporated with limited liability as an open-ended investment 
company with variable capital under the laws of Ireland with registered number 
                                    548554 
 
       Registered Office: 33 Sir John Rogerson's Quay, Dublin 2, Ireland 
 
Date:    10 February 2022 
 
Re:       Extraordinary General Meeting of the Fund 
 
Dear Shareholder, 
 
We are writing to you to notify you that the Directors of the Company wish to 
convene an Extraordinary General Meeting of the Fund at the Company's 
registered office 33 Sir John Rogerson's Quay, Dublin 2, Ireland on 2 March 
2022 at 10.30 a.m. (Irish Time) (the "EGM" / "Meeting"), at which shareholders 
will be asked to approve the proposed amendment to the investment objective of 
the Fund (the "Proposed Amendment") and an ordinary resolution. The Fund will 
continue to follow the same investment policy and strategy employed by the 
Manager since the inception of the Fund. Furthermore, it is not expected that 
this proposal changes the risk profile of the Fund or that it will have an 
impact on the anticipated tracking error. 
 
As the Fund uses the International Central Securities Depository ("ICSD") model 
of settlement and Citivic Nominees Limited is the sole registered shareholder 
of Shares in the Fund under the ICSD settlement model, physical attendance of 
investors who are not registered shareholders does not take place at general 
meetings of the Fund or of the Company, investors in the Fund should send 
voting instructions through the relevant ICSD or the relevant participant in an 
ICSD (such as a local central securities depository). If any investor has 
invested in the Fund through a broker/dealer/other intermediary, the investor 
should contact this entity or its relevant proxy voting agent to provide voting 
instructions. 
 
All capitalised terms used in this notice shall bear the same meaning as the 
capitalised and defined terms used in the Prospectus and Supplement. 
 
1         PROPOSED AMMENT REQUIRING SHAREHOLDER APPROVAL 
 
Subject to Shareholder approval and the requirements of the Central Bank, it is 
proposed to amend the investment objective of the Fund as follows: 
 
"The Fund's investment objective is to replicate, before fees and expenses, the 
MVIS US Listed Semiconductor 10% Capped ESG Index (the Index). For a further 
description of the Index see the section entitled Information on the Index 
below" 
 
A mark-up showing the Proposed Amendment which Shareholders are being asked to 
approve and further information on the Re-Named Index is set out in Appendix 3. 
 
2         RATIONALE FOR THE PROPOSED AMMENT 
 
The Directors, following engagement with the Manager, are proposing to change 
the investment objective of the Fund by changing the relevant index which the 
Fund seeks to replicate, before fees and expenses. It is proposed that the Fund 
will, subject to the passing of necessary resolution, seek to replicate, before 
fees and expenses, the price and yield of the MVIS US Listed Semiconductor 10% 
Capped ESG Index (the "Re-Named Index"). 
 
The Proposed Amendment is being proposed as part of the Company's continuous 
review of its existing product range and due to increased demand for ESG 
compliant investments. The Company believes that the Re-Named Index, 
which consists of companies that meet certain minimum Environmental, Social and 
Governance ("ESG") standards, will increase its sustainable footprint by 
focusing its investment strategy on sustainable investment strategies. The 
differences between the prior index and the Re-Named Index (which are both 
calculated by the same issuer) include, but are not limited to, the following: 
 
(a)        ESG screening: The index selection process screens out: 
 
-     Companies with very severe social norms violations according to ISS 
research 
 
-     Companies that have greater than 0% revenue exposure to controversial 
weapons, including, among others: Anti-personnel Mines, Biological Weapons, 
Chemical Weapons, Cluster Munitions, Depleted Uranium, Nuclear Weapons, 
Incendiary Weapons and White Phosphorus 
 
-     Companies that exceed certain thresholds of revenue exposure to various 
sectors including but not limited to civilian firearms, tobacco, gambling, 
military equipment and energy extractives (eg Thermal Coal, Fossil Fuels, Oil 
Sands and Nuclear Power). 
 
(b)        Companies that are not covered by ISS or for which relevant data 
fields are not collected by ISS may be eligible for inclusion. 
 
The anticipated tracking error and the risk profile of the Fund are expected to 
remain the same, following the transition to the Re-Named Index. The Fund 
composition is expected to change moderately to reflect the introduced ESG 
constraints and targets. The Total Expense Ratio will not change as a result of 
the proposed change to the Re-Named Index. 
 
3         SHAREHOLDERS' APPROVAL 
 
For the sanctioning of the resolution to approve the Proposed Amendment, the 
Shareholder of the Fund must pass the ordinary resolution. The required quorum 
at the Meeting is one shareholder present in person or by proxy. 
 
If such approval is obtained, the changes will be effected on or around 18 
March 2022 ("Effective Date") subject to the requisite regulatory approvals 
being obtained, with the exact date to be announced via the regulatory news 
service of Euronext Dublin and to be published in an appropriate manner in each 
of the other jurisdictions in which the Fund's shares are listed on a stock 
exchange. 
 
The supplement for the Fund and the Key Investor Information Document (KIID) 
will be updated at the Effective Date or as soon as possible thereafter, 
subject to the approval by the Central Bank of Ireland and subject to any 
changes as may be required by the Central Bank of Ireland. 
 
4         RECOMMATION 
 
The Directors believe that the proposed resolution is in the best interests of 
the shareholders of the Fund as a whole and, accordingly, recommend that you 
vote in favour of the proposed resolution. 
 
5         PUBLICATION OF RESULTS 
 
The result of the EGM will be announced through the regulatory news service on 
Euronext Dublin website and will be published in an appropriate manner in each 
of the other jurisdictions in which the Company is listed on a stock exchange. 
 
Yours faithfully, 
 
Director 
 
VanEck Vectors UCITS ETFs plc 
 
 
 
                                  APPIX 1 
 
 
                    NOTICE OF EXTRAORDINARY GENERAL MEETING 
 
           OF VanEck Vectors T Semiconductor UCITS ETF (the "FUND") 
 
                                 a sub-fund of 
 
                 VANECK VECTORS UCITS ETFs PLC (THE "COMPANY") 
 
NOTICE IS HEREBY GIVEN  that the Extraordinary General Meeting of the 
shareholders of the Fund will be held at 33 Sir John Rogerson's Quay, Dublin 2, 
Ireland on 2 March 2022 at 10:30 a.m. (Irish Time) for the following purpose: 
 
 
RESOLUTION 
 
That the investment objective of the Fund, as detailed in section 1 of the 
Circular dated 10 February 2022, be changed to reflect the change of the index 
of the Fund, subject to any amendments required by the Central Bank of Ireland. 
 
 
By order of the Directors. 
 
Dated this 10th day of February 2022 
 
Tudor Trust Limited Registered in Dublin, Ireland - No: 192532. 
 
 
 
Notes 
 
Quorum 
 
1         The required quorum at the meeting is one shareholder present in 
person or by proxy. If a quorum is not present within half an hour from the 
appointed time for the meeting, or if during a meeting a quorum ceases to be 
present, the meeting shall stand adjourned to the following week (9 March 2022) 
at the same time and place, or to such other day and at such other time and 
place as the Directors may determine. 
 
Entitlement to attend and vote 
 
2         Only a registered shareholder is entitled to attend, speak, ask 
questions and vote at the meeting (or any adjournment thereof). As sub-funds in 
the Company use the International Central Securities Depositary (ICSD) model of 
settlement and Citivic Nominees Limited is the sole registered shareholder of 
shares in the sub-funds under the ICSD settlement model, investors in the 
sub-fund should submit their voting instructions through the relevant ICSD or 
the relevant participant in an ICSD (such as a local central securities 
depositary). If any investor has invested in the sub-fund through a broker/ 
dealer/other intermediary, the investor should contact this entity or its 
relevant proxy voting agent to provide voting instructions. 
 
Appointment of proxies 
 
3         A form of proxy is enclosed with this Notice of the EGM for use by 
registered shareholders. As mentioned above, investors in the sub-fund who are 
not registered shareholders should submit their voting instructions through the 
relevant ICSD or the relevant participant in an ICSD (such as a local central 
securities depositary, broker or nominee), instead of using the form of proxy. 
To be effective, the form of proxy duly completed and executed, together with a 
copy of the power of attorney or other authority under which it is executed 
must be deposited by registered shareholders at the offices of the office of 
the Company Secretary, Tudor Trust Limited, 33 Sir John Rogerson's Quay, Dublin 
2, Ireland, so as to be received no later than 24 hours before the time 
appointed for the EGM or any adjournment thereof or (in the case of a poll 
taken otherwise than at or on the same day as the EGM or adjourned EGM) at 
least 24 hours before the taking of the poll at which it is to be used. Any 
alteration to the form of proxy must be initialled by the person who signs it. 
 
4         Subject to the Articles of Association of the Company and provided it 
is received at least 24 hours before the time appointed for the holding of the 
EGM or any adjournment thereof or (in the case of a poll taken otherwise than 
at or on the same day as the EGM or adjourned EGM) at least 24 hours before the 
taking of the poll at which it is to be used, the appointment of a proxy may 
also be submitted electronically to tudortrust@dilloneustace.ie entering the 
company name. 
 
Voting rights and total number of issued shares in the sub-fund 
 
5         At the EGM, the resolutions put to the vote of the meeting may be 
decided on a poll. On a poll every shareholder shall have one vote for every 
share of which he is the shareholder. 
 
6         Where a poll is taken at an EGM any member, present or by proxy, 
holding more than one share is not obliged to cast all his/her votes in the 
same way. 
 
7         Ordinary resolutions require to be passed by a simple majority of 
members voting in person or by proxy. Special resolutions require a majority of 
not less than 75% of votes cast by those who vote either in person or in proxy 
to be passed. 
 
 
 
                                  APPIX 2 
 
 
                                 FORM OF PROXY 
 
             VanEck VectorsT Semiconductor UCITS ETF (the "Fund") 
 
                                 a sub-fund of 
 
                 VANECK VECTORS UCITS ETFs PLC (THE "COMPANY") 
 
I/We*                                        of 
 
being a Shareholder in the Fund and entitled to vote, hereby appoint the 
Chairman of the Meeting or failing him/her Laura Tully of 33 Sir John 
Rogerson's Quay, Dublin 2, Ireland or failing her a representative of Tudor 
Trust Limited as my/our* proxy to vote for me/us* on my/our* behalf at the 
Extraordinary General Meeting of the Company to be held at 33 Sir John 
Rogerson's Quay, Dublin 2, Ireland on 2 March 2022 at 10:30 a.m. (Irish Time) 
or any reconvened meeting thereof. 
 
(*delete as appropriate) 
 
 
Signature: 
 
Date:                             2022 
 
Please indicate with an "X" in the spaces below how you wish your vote to be 
cast in respect of the resolution. If no specific direction as to voting is 
given, the proxy will vote or abstain from voting at his/her discretion. If you 
elect to abstain from voting with respect to the resolution, such election will 
not count as a vote in law and will not be counted in the calculation of the 
proportion of the votes for and against the resolution. 
 
RESOLUTION:                                                     For     Against    Abstain 
 
1.   That the investment objective of the Fund, as detailed 
in section 1 of the Circular dated 10 February 2022, be 
changed to reflect the change of the index of the Fund, 
subject to any amendments required by the Central Bank of 
Ireland. 
 
IF RELEVANT, PLEASE PRINT YOUR NAME OR THE NAME OF THE CORPORATION YOU ARE 
EXECUTING THIS FORM ON BEHALF OF AND YOUR ADDRESS UNDERNEATH 
 
Print Name: 
_____________________________________________________________________ 
 
Print Address 
____________________________________________________________________ 
 
____________________________________________________________________________ 
 
Notes 
 
1         A shareholder must insert his/her full name and registered address in 
type or block letters. In the case of joint accounts the names of all holders 
must be stated. Please insert your name(s) and address in BOLD TYPE and sign 
and date the form. 
 
2         Only a registered shareholder is entitled to attend, speak, ask 
questions and vote at the Meeting (or any adjournment thereof). As sub-funds in 
the Company use the International Central Securities Depositary (ICSD) model of 
settlement and Citivic Nominees Limited is the sole registered shareholder of 
shares in the sub-funds under the ICSD settlement model, physical attendance of 
investors who are not registered shareholders does not take place at general 
meetings of the Fund or of the Company and investors in the Fund should send 
voting instructions through the relevant ICSD or the relevant participant in an 
ICSD (such as a local central securities depository). If any investor has 
invested in the Fund through a broker/dealer/other intermediary, the investor 
should contact this entity or its relevant proxy voting agent to provide voting 
instructions. 
 
3         The Form of Proxy must: 
 
·             in the case of an individual shareholder, be signed by the 
shareholder or his attorney; and 
 
·             in the case of a corporate shareholder, be executed under its 
common seal or under the hand of some officer, attorney or other person duly 
authorised to act on its behalf. 
 
4         Indicate by placing a cross in the appropriate box how you wish your 
votes to be cast in respect of each resolution. If no mark is made, your proxy 
may vote or abstain at his/her discretion. On any other business not specified 
in the Notice of Meeting and arising at the Meeting, the proxy will act at his 
or her discretion. 
 
5         To be valid, this form (and, if applicable, any power of attorney or 
other authority under which it is signed or a notarially certified copy 
thereof) must be completed and deposited at the office of the Company 
Secretary, Tudor Trust Limited, at 33 Sir John Rogerson's not less than 24 
hours before the time appointed for the holding of the meeting by post or by 
fax at +353 (0) 1 667 0042 for the attention of Laura Tully. Citivic Nominees 
Limited may send their signed Form of Proxy by e-mail to 
tudortrust@dilloneustace.ie. Any proxy form deposited less than 24 hours before 
the time of the meeting may only be treated as valid at the discretion of the 
Directors. Failure to return the proxy form by the required time will (subject 
to the aforementioned discretion of the Directors) result in the proxy form 
being void and your proxy will not be entitled to vote on your behalf as 
directed. 
 
 
 
                                  APPIX 3 
 
           Proposed amendments to the Index and investment objective 
 
Investment Objective 
 
"The Fund's investment objective is to replicate, before fees and expenses, the 
MVIS US Listed Semiconductor 10% Capped ESG Index (the Index).  For a further 
description of the Index see the section entitled Information on the Index 
below." 
 
Information on the Index 
 
The Index includes companies engaged primarily in the production of 
semiconductors and semiconductor equipment. The Index includes US 
exchange-listed companies that derive at least 50% of their revenues from 
semiconductors. However, where the Index already holds such equity securities 
and the percentage of revenue generated falls, the Index will only seek to 
remove the security when the percentage of revenue generated from 
semiconductors drops below 25% of the relevant companies revenues. 
 
The Index considers ESG factors as further detailed in the Index methodology 
available on the Index Providers website. The Index Provider will utilize ESG 
data provided by ISS. Companies with very severe social norms violations, have 
greater than 0% revenue exposure to controversial weapons, or that exceed 
certain thresholds of revenue exposure to various sectors including but not 
limited to civilian firearms, tobacco, and energy extractives are not eligible 
for inclusion. Further, companies that are not covered by ISS or for which 
relevant data fields are not collected by ISS may be eligible for inclusion. 
 
The Index employs a 10% capping scheme to ensure diversification. If a 
component exceeds the maximum weight at the time of Index rebalancing, then the 
weight will be reduced to the maximum weight and the excess weight shall be 
redistributed proportionally across all other (uncapped) Index constituents. 
This process is repeated until no component weight exceeds the maximum weight. 
 
Changes to the Index other than to the index components will be implemented and 
based on the closing prices of the third Friday of every quarter-end month 
(i.e. March, June, September and December). If the third Friday is not a 
business day, the review will take place on the last business day before the 
third Friday. If a company does not trade on the third Friday of a quarter-end 
month, then the last available price for this company will be used. Changes 
become effective on the next business day. 
 
The Index components are rebalanced on a semi-annual basis in March and 
September so that the Index components continue to represent the universe of 
companies involved in the production of semiconductors and semiconductor 
equipment. The target coverage of the Index is 25 companies. 
 
The following steps will be followed and form the Index review procedure: 
 
1.           The largest 50 stocks (by full market capitalisation) from the 
investable universe qualify for inclusion in the Index. 
 
2.           The 50 stocks which qualify for inclusion in the Index are ranked 
in two different ways - by free-float market capitalisation in descending order 
(the largest companies receives rank "1") and then by three-month 
average-daily-trading volume in descending order (the most liquid companies 
receives rank "1"). These two ranks are added up. 
 
3.           The 50 stocks are ranked now by their sum of the two ranks in step 
2 in ascending order. If two companies have the same sum of ranks, then the 
larger company is placed on top. 
 
a.   Initially, the highest ranked 25 companies made up the Index. 
 
On-going, a 10-40 buffer is applied: The highest ranked 10 companies qualify. 
The remaining 15 companies are selected from the highest ranked remaining 
current index components ranked between 11 and 40. If the number of selected 
companies is still below 25, then the highest ranked remaining stocks are 
selected until 25 companies were selected. 
 
For all corporate events that result in a stock deletion from the Index, the 
deleted stock will be replaced with the highest ranked non-component on the 
most recent selection list immediately only if the number of components in the 
Index would drop below 20. The replacement stock will be added at the same 
weight as the deleted stock. Only in case the number of components drops below 
its minimum due to a merger of two or more index components, the replacement 
stock will be added with its uncapped free-float market capitalisation weight. 
In all other cases, i.e. there is no replacement, the additional weight 
resulting from the deletion will be redistributed proportionally across all 
other index constituents. 
 
 
 
END 
 
 

(END) Dow Jones Newswires

February 10, 2022 10:44 ET (15:44 GMT)

Vaneck Smh (LSE:SMH)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Vaneck Smh
Vaneck Smh (LSE:SMH)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Vaneck Smh